← Leaderboards
Elizabeth Schramm
Serion, Inc.
$744,409
Attributed
$744,409
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $298.9K · FY2017–19$500K$375K$250K$125K$0
'17
'18
'19
Funding mix
By agency
NIH$744,409 · 3
By mechanism
R43$744,409 · 3
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Interest”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Leonard Freedman · Leidos Biomedical Research, Inc.$50,428,847
- Julie Brisset · The University Of Central Florida Board Of Trustees$41,275,036
- Gary Kobinger · University Of Texas Med Br Galveston$34,500,000
- Lynn Briscoe · Leidos Biomedical Research, Inc.$33,108,860
Research focus
InterestSmall Business Innovation Research GrantProteinsAreaFeasibility StudiesGenerationsFormulationGenesElectric FieldCrispr/Cas TechnologyEngineeringElectrophoresisFrequenciesBaseCellsCell TypeCancer TherapyCell SurvivalCellular MembraneComplementDesignDevicesAcousticsCell Line
Grant awards (3)
Developing a Platform for Multiplexed Large Payload Delivery$298,853
R43 · FY2019 · CA · contact PI
Establishing the POROS Intracellular Delivery System as a Platform for Cellular Therapeutics$247,405
R43 · FY2018 · CA · contact PI
Targeting the alternative pathway to treat age-related macular degeneration$198,151
R43 · FY2017 · EY · contact PI